Gender Differences in Patients Treated for HCV: Efficacy and Safety of Sofosbuvir/Velpatasvir in Women
dc.contributor.author | Tran, TT | en_US |
dc.contributor.author | Feld, JJ | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Naik, S | en_US |
dc.contributor.author | Eggleton, ES | en_US |
dc.contributor.author | Zhang, J | en_US |
dc.contributor.author | Natha, M | en_US |
dc.contributor.author | Llewellyn, J | en_US |
dc.contributor.author | Kreter, B | en_US |
dc.contributor.author | Brainard, DM | en_US |
dc.contributor.author | Wyles, DL | en_US |
dc.contributor.author | Sulkowski, MS | en_US |
dc.contributor.author | Rogal, SS | en_US |
dc.date.accessioned | 2017-06-01T14:06:35Z | |
dc.date.issued | 2016-10 | en_US |
dc.date.submitted | 2017-01-04T08:27:39.830Z | |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23494 | |
dc.description | Meeting Abstract | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.format.extent | 422A - 422A | en_US |
dc.title | Gender Differences in Patients Treated for HCV: Efficacy and Safety of Sofosbuvir/Velpatasvir in Women | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 64 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1168]